China Biotech Services Holdings Limited (8037.HK) Stock Overview
Explore China Biotech Services Holdings Limited’s financial performance, market position, analyst ratings, and future outlook.
China Biotech Services Holdings Limited (8037.HK)
Key Financials
Key Financials
Market Cap
609.8M
P/E Ratio
-8.95
EPS (TTM)
$-0.20
ROE
-0.31%
8037.HK Stock Analysis & Investment Overview (HKSE)
Our AI-powered analysis of China Biotech Services Holdings Limited (HKSE: 8037.HK) gives investors deep insight into how the stock performs on the HKSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, China Biotech Services Holdings Limited's HKSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of 8037.HK on the HKSE shows an RSI of 50.94, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.81 for the HKSE listing.
Key metrics behind China Biotech Services Holdings Limited's HKSE-traded stock include a P/E ratio of -8.95 and a market capitalization of 609.8M. Combined with our AI analysis, these give both institutional and retail investors a clear view of 8037.HK on the HKSE.